Dublin, Jan. 12, 2018 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Forecast in 21 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer, but the most common of the endocrine system. The main clinical split is between differentiated and undifferentiated tumour types, with the majority being well-differentiated.

This report provides the current incident population for thyroid cancer across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Saudi Arabia, South Africa, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several features of thyroid cancer patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of thyroid cancer include:

• Familial Adenomatous Polyposis
• Acromegaly
• Diabetes
• Multiple endocrine neoplasia syndromes
• Sipple syndrome
  

Reasons to Buy:

• Ability to quantify patient populations in global thyroid cancer market to target the development of future products, pricing strategies and launch plans.
• Further insight into the incidence of the subdivided types of thyroid cancer and identification of patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Better understanding of the impact of specific co-morbid conditions on the incident population of thyroid cancer patients.
• Identification of thyroid cancer patient sub-populations that require treatment.
• Better understanding of the specific markets that have the largest number of thyroid cancer patients.

Key Topics Covered:

1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions / Features Associated With the Disease
8. Methodology for Quantification of Patient Numbers
9. Additional Data Available on Request
10. Top-Line Incidence for Thyroid Cancer
11. Features of Thyroid Cancer Patients
12. Papillary Thyroid Cancer Patients
13. Comorbidities of Thyroid Cancer Patients
14. Abbreviations Used in the Report
15. Other Services & Solutions
16. Reports & Publications
17. Online Epidemiology Databases
18. Online Pharmaceutical Pricing Database
19. References
20. Appendix
    

For more information about this report visit https://www.researchandmarkets.com/research/zfnxr2/thyroid_cancer?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Oncology Drugs